| Amber Stock, PARMD | |
|
2490 Ne Highway 99w, Mcminnville, OR 97128-9204 | |
| (503) 435-3125 | |
| Not Available |
| Full Name | Amber Stock |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2490 Ne Highway 99w, Mcminnville, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417545831 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 0018116 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amber Stock, PARMD 2490 Ne Highway 99w, Mcminnville, OR 97128-9204 Ph: () - | Amber Stock, PARMD 2490 Ne Highway 99w, Mcminnville, OR 97128-9204 Ph: (503) 435-3125 |
News Archive
The Allstate Corporation today announced that it has obtained all required regulatory approvals and closed its acquisition of Esurance and Answer Financial from White Mountains Insurance Group, Ltd.. The purchase price was approximately $1 billion. The transaction is expected to be non-dilutive to Allstate's earnings in the second full year of ownership.
Scientists have uncovered evidence that a deficiency in the skin's barrier is key to triggering eczema. The team at Newcastle University, in collaboration with scientists at Stiefel, a GSK company, have identified how a key skin barrier protein called filaggrin impacts on other proteins and pathways in the skin, which in turn drive the development of eczema.
The findings of the study, published online in the journal Nature Medicine, have important implications for developing new treatments for HIV, especially for patients with chronic infection who fail to respond to antiretroviral regimens.
At the neonatology ward of the Vienna General Hospital, physicians compared two mixtures of intravenous lipids for nutrition with support coming from the FWF. The researchers found no amelioration with respect to bile-flow complications in extremely low birth weight preterm babies in incubators, but they did discover more mature brain waves.
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, the University of Birmingham and Cancer Research Technology, the commercialisation arm of Cancer Research UK, announces today the launch of a collaboration to develop a new immuno-oncology cellular therapy based on gene modifying T cells to target solid tumours.
› Verified 9 days ago
Vernon Neal Utz Jr., PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2490 N Highway 99w, Mcminnville, OR 97128 Phone: 503-435-3125 | |
Marilyn Kay Levy, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 603 Se Baker St, Mcminnville, OR 97128 Phone: 503-474-3795 | |
Teresa Ailynn Smith, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 615 Sw Keck Dr, Mcminnville, OR 97128 Phone: 503-474-0894 | |
Kristina Madrigal, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2700 Se Stratus Ave, Mcminnville, OR 97128 Phone: 503-472-6540 | |
Keven Peterson, 1835P0018X Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2490 Ne Highway 99w, Mcminnville, OR 97128 Phone: 503-435-3125 Fax: 503-435-3128 | |
Susan Mckerrall-fuller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2490 N Highway 99w, Mcminnville, OR 97128 Phone: 503-435-3125 Fax: 503-435-3128 | |
Dr. Nathan Pelzer, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 615 Sw Keck Dr, Mcminnville, OR 97128 Phone: 503-474-0894 |